Exact Mass: 393.98900100000003
Exact Mass Matches: 393.98900100000003
Found 79 metabolites which its exact mass value is equals to given mass value 393.98900100000003,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Isorhamnetin 3-sulfate
C16H10O10S (393.99946800000004)
Kaempferol 7,4-dimethyl ether 3-O-sulfate
C17H14O9S (394.03585140000007)
(2RS,4RS,7SR,9aSR)-7-bromo-2-(bromomethyl)decahydro-6,6,9a-trimethyl-3-methylidene-1-benzoxepin-4-ol|4-hydroxypalisadin C
C15H24Br2O2 (394.01429239999993)
1-[(E)-but-2-en-2-yl]-2,8-dichloro-3,9-dihydroxy-4,7-dimethylbenzo[b]-[1,4]-benzodioxepin-6-one|2,7-Dichlor-3,8-dihydroxy-1,9-dimethyl-6-(1-methyl-propenyl)-dibenzo[b,e][1,4]dioxepin-11-on|2,7-dichloro-3,8-dihydroxy-1,9-dimethyl-6-(1-methyl-propenyl)-dibenzo[b,e][1,4]dioxepin-11-one|aspergillusidone C
1-[(Z)-but-2-en-2-yl]-2,8-dichloro-3,9-dihydroxy-4,7-dimethylbenzo[b][1,4]benzodioxepin-6-one
1h,1h,2h,3h,3h-perfluorononane-1,2-diol
C9H7F13O2 (394.02384379999995)
1,5,5-trimethyl-3-(4-methylphenyl)sulfonyl-4H-imidazol-1-ium,iodide
diphenyliodonium trifluoroacetate
C14H10F3IO2 (393.96776259999996)
1-(3-CHLOROPHENYL)-3-(1-(3,4-DICHLOROBENZYL)-1H-PYRAZOL-3-YL)UREA
4-{[3-chloro-5-(trifluoromethyl)-2-pyridinyl]oxy}-N-isopropylbenzenesulfonamide
2-[[1-oxo-2-(1H-1,2,4-triazol-5-ylthio)ethyl]amino]-4-thiophen-2-yl-3-thiophenecarboxylic acid ethyl ester
Dithionitrobenzoic acid
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D013439 - Sulfhydryl Reagents
[(2R)-2-amino-3-(carboxymethylamino)-3-oxopropyl]sulfanyl-methylmercury
(2R,3R,4R,5R,6R)-2-[[(2S,3R,4S,5S)-2,5-bis(chloromethyl)-3,4-dihydroxyoxolan-2-yl]methyl]-5-chloro-6-(hydroxymethyl)oxane-3,4-diol
7-Hydroxy-2-(3-methoxy-4-oxidophenyl)-4-oxo-3-sulfooxychromen-5-olate
C16H10O10S-2 (393.99946800000004)
2-(4-bromophenoxy)-N-[(2-hydroxy-5-methylanilino)-sulfanylidenemethyl]acetamide
C16H15BrN2O3S (393.99867000000006)
N-(6-methylsulfonyl-1,3-benzothiazol-2-yl)-4-oxo-4-thiophen-2-ylbutanamide
C16H14N2O4S3 (394.01156840000004)
ethyl 2-[(2-chlorophenyl)sulfanylmethyl]-5-methyl-4-oxo-3H-thieno[2,3-d]pyrimidine-6-carboxylate
C17H15ClN2O3S2 (394.02125900000004)
2-Bromo-4-chloro-6-[[4-(4-morpholinyl)anilino]methylidene]-1-cyclohexa-2,4-dienone
Ethyl 5-phenyl-1-(2,4,6-trichlorophenyl)pyrazole-4-carboxylate
5-[(2-Bromo-6-chlorophenyl)methyl]-1-tert-butyl-4-pyrazolo[3,4-d]pyrimidinone
4-[(1-Methyl-5-tetrazolyl)thio]-5-[3-(trifluoromethyl)phenyl]thieno[2,3-d]pyrimidine
4-[(1-Methyl-5-tetrazolyl)thio]-5-[2-(trifluoromethyl)phenyl]thieno[2,3-d]pyrimidine
4-[(1-Methyl-5-tetrazolyl)thio]-5-[4-(trifluoromethyl)phenyl]thieno[2,3-d]pyrimidine
(11-Hydroxy-16,18-dioxo-6,8,19-trioxapentacyclo[10.7.0.02,9.03,7.013,17]nonadeca-1(12),2(9),4,10,13(17)-pentaen-14-yl) hydrogen sulate
C16H10O10S (393.99946800000004)
M1002
C15H8F6N2O2S (394.02106599999996)
M1002 is a hypoxia-inducible factor-2 (HIF-2) agonist, and can enhance the expression of HIF-2 target genes. M1002 shows synergy with prolyl-hydroxylase domain (PHD) inhibitors[1].
(5s)-5-[(1s,2e)-10,10-dibromo-1-hydroxydeca-2,9-dien-1-yl]oxolan-2-one
C14H20Br2O3 (393.97790899999995)
5-(10,10-dibromo-1-hydroxydeca-2,9-dien-1-yl)oxolan-2-one
C14H20Br2O3 (393.97790899999995)
(5r)-5-[(1r,2e)-10,10-dibromo-1-hydroxydeca-2,9-dien-1-yl]oxolan-2-one
C14H20Br2O3 (393.97790899999995)
(3r,5r,6r,8s,11s)-11-bromo-6-(bromomethyl)-5,8,12,12-tetramethyl-4,7-dioxatricyclo[6.4.0.0³,⁵]dodecane
C15H24Br2O2 (394.01429239999993)
2-amino-1-{3,5-dibromo-4-[3-(dimethylamino)propoxy]phenyl}ethanol
C13H20Br2N2O2 (393.98914199999996)
(5r)-5-[(1s,2e)-10,10-dibromo-1-hydroxydeca-2,9-dien-1-yl]oxolan-2-one
C14H20Br2O3 (393.97790899999995)
(5s)-5-[(1e,3r)-10,10-dibromo-3-hydroxydeca-1,9-dien-1-yl]oxolan-2-one
C14H20Br2O3 (393.97790899999995)
methyl 5-bromo-10-hydroxy-8-methyl-3,11-dioxo-1h-oxepino[4,3-b]chromene-1-carboxylate
4-[2-(5-bromo-2-oxo-1h-indol-3-ylidene)hydrazin-1-yl]benzenesulfonamide
C14H11BrN4O3S (393.97351960000003)
4-[(2e)-but-2-en-2-yl]-5,15-dichloro-6,14-dihydroxy-7,12-dimethyl-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaen-10-one
[5-hydroxy-7-methoxy-2-(4-methoxyphenyl)-4-oxochromen-3-yl]oxidanesulfonic acid
C17H14O9S (394.03585140000007)
[(2r,7s,9as)-7-bromo-2-(bromomethyl)-6,6,9a-trimethyl-2,5,5a,7,8,9-hexahydro-1-benzoxepin-3-yl]methanol
C15H24Br2O2 (394.01429239999993)
(5s)-5-[(1r,2e)-10,10-dibromo-1-hydroxydeca-2,9-dien-1-yl]oxolan-2-one
C14H20Br2O3 (393.97790899999995)
[(2r,5as,7s,9as)-7-bromo-2-(bromomethyl)-6,6,9a-trimethyl-2,5,5a,7,8,9-hexahydro-1-benzoxepin-3-yl]methanol
C15H24Br2O2 (394.01429239999993)
(1r)-2-amino-1-{3,5-dibromo-4-[3-(dimethylamino)propoxy]phenyl}ethanol
C13H20Br2N2O2 (393.98914199999996)
(5r)-5-[(1e,3s)-10,10-dibromo-3-hydroxydeca-1,9-dien-1-yl]oxolan-2-one
C14H20Br2O3 (393.97790899999995)
(5s)-5-[(1e,3s)-10,10-dibromo-3-hydroxydeca-1,9-dien-1-yl]oxolan-2-one
C14H20Br2O3 (393.97790899999995)
5-(10,10-dibromo-3-hydroxydeca-1,9-dien-1-yl)oxolan-2-one
C14H20Br2O3 (393.97790899999995)
(2r,4r,7s,9as)-7-bromo-2-(bromomethyl)-6,6,9a-trimethyl-3-methylidene-hexahydro-2h-1-benzoxepin-4-ol
C15H24Br2O2 (394.01429239999993)